In this article, Dexcom announced an artificial intelligence feature for its Stelo continuous glucose monitor that provides users with personalized insights into how meals, sleep, and activity affect their glucose levels. This feature is part of a new generative AI platform developed in collaboration with Google Cloud.
Stelo is a non-prescription CGM that measures real-time blood sugar levels by penetrating the skin. Launched in August, the sensor is suitable for use by any adult not taking insulin.
The introduction of this AI feature reflects Dexcom’s efforts to enhance the personalization and user engagement of Stelo as it seeks to expand into a new market. Jake Leach, Dexcom’s chief operating officer, mentioned that users have expressed a desire for more insights to maximize the benefits of the data generated by wearing the product.
Dexcom is leveraging Google’s Gemini models and Vertex AI platform to power its new AI offering. Vertex AI enables developers to create applications that integrate various data types, a complex task in the healthcare sector.
While considering extending the AI platform to other CGM products, Dexcom is proceeding cautiously due to the critical role these devices play in preventing medical emergencies. The company chose Stelo as the initial platform for this AI integration.
Previously, Stelo users had access to a standard insights report within the app on a weekly basis. The new AI-generated report is expected to be more valuable as it is tailored to individual users, offering personalized recommendations and educational content based on their activity levels.
The AI reports provided by Stelo do not offer medical advice, and Dexcom has collaborated with the U.S. Food and Drug Administration to ensure compliance with regulatory standards. The FDA approved Stelo in March.
Dexcom aims to evolve its generative AI platform to provide real-time feedback to users and potentially serve as an early warning system for health issues, akin to a car’s check engine light. The company is exploring ways to enhance user experience and provide proactive guidance through this technology.
The updated weekly report with AI insights has started rolling out to Stelo users this week, marking a significant advancement in Dexcom’s efforts to enhance the functionality and user experience of its CGM products.
